Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin analogue versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery
ACTRN12608000396325Phase 4Active, not recruiting
- Sponsor
- Farouk Systems
- Start
- Dec 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of carbetocin and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Farouk Systems. Primary endpoint: Requirement for additional intervention. Started Dec 2006; status: active, not recruiting.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12608000396325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000396325.